Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.

MLA

Inoue, Satoshi, et al. “Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer.” PloS One, vol. 7, no. 2, 2012, p. e31070. EBSCOhost, https://doi.org/10.1371/journal.pone.0031070.

APA

Inoue, S., Patil, R., Portilla-Arias, J., Ding, H., Konda, B., Espinoza, A., Mongayt, D., Markman, J. L., Elramsisy, A., Phillips, H. W., Black, K. L., Holler, E., & Ljubimova, J. Y. (2012). Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer. PloS One, 7(2), e31070. https://doi.org/10.1371/journal.pone.0031070

Chicago

Inoue, Satoshi, Rameshwar Patil, Jose Portilla-Arias, Hui Ding, Bindu Konda, Andres Espinoza, Dmitriy Mongayt, et al. 2012. “Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer.” PloS One 7 (2): e31070. doi:10.1371/journal.pone.0031070.